A further limitation of this study is the lack of availability of a concurrent glucose level when C - peptide was measured ; it is recognisedcan resultin a reduced C - peptide result
S294Aresultedin loss of peptide C. C
any drugcausingINSULIN C - PEPTIDE DECREASED
two T1DM patientsresultedin increased C - peptide
One researchdiscoveredhigher C - peptide
Both of the treatmentscausedan increase in C - peptide
If higherleadsto higher C - peptide
higher TNFleadsto higher C - peptide
metabolic stimuli(passive) are influenced byC - peptide and proinsulin levels
Transfection of neurons in the arcuate nucleus of the hypothalamusledto a decrease in AGRP peptide immunoreactivity
S47A / S104A / S106A / S118Aresultedin loss of peptide D.
All substitutionscausedthe reduction of peptide hydrophobicity
an increase in protein stabilizationwould resultin a decrease in proteolytic peptides
Drugsmay causeincreased levels of C - peptide
by the dietary treatments(passive) caused byC - peptide excretion
What other factors besides agingcan causea decrease in peptides
renal failurecan causeincreased levels of C - peptide
proteinscontributingto decreased peptides
on normal human blood samples(passive) can therefore be discoveredC - peptide
on normal human blood samples(passive) can subsequently be discoveredC - peptide
first(passive) was ... discoveredC - peptide
on regular human blood samples(passive) can therefore be discoveredC - peptide
on regular human blood samples(passive) can subsequently be discoveredC - peptide
on the other hand(passive) is composedC - peptide
of 31 amino acids(passive) is composedC - peptide
by the route of insulin administration(passive) is ... influenced byC - peptide
by the route of insulin administration(passive) is ... influencedC - peptide
A high molar ratio of metal saltmay resultC - peptide
in 1967(passive) was discoveredC - peptide
to have biological activity itself(passive) has ... been discoveredC - peptide
to have itself biological activity(passive) has ... been discoveredC - peptide
in 1967. Other names for it(passive) was discovered C - Peptide
Bing Xu of Brandeis University and colleaguesdesigneda nonnurturing peptide
from proinsulin , which is synthesized in the beta - cells of the Islets of Langerhans and cleaved enzymatically releasing insulin and C - peptide(passive) is originatedC - peptide
patients with high use(passive) influenced byCalcineurin Autoinhibitory Peptide
Tag ... an epitopecomposedof a 12residue peptide
As many features and their combinations affect immunogen design , machine - learning approaches and protein 3D structure / informatics - based programmes are usedto designpeptide immunogens
to an increase in several different diseases of aging , particularly in dementiacould leadto an increase in several different diseases of aging , particularly in dementia
from a given change in T cellswould resultfrom a given change in T cells
Both of RGD4C and(passive) were discoveredBoth of RGD4C and
from proinsulin together with insulinoriginatesfrom proinsulin together with insulin
specific translocation of PKC isoformscausesspecific translocation of PKC isoforms
elements(passive) influenced byelements
Man nuclei as well as(passive) were discoveredMan nuclei as well as
an influx of calciumcausesan influx of calcium
from the transplantsoriginatedfrom the transplants
Na+K+-ATPase and endothelial nitric oxide synthase activitymay influenceNa+K+-ATPase and endothelial nitric oxide synthase activity
vasodilationcausesvasodilation
Na+K+-ATPase and endothelial nitric oxide synthase activity in order to exert its beneficial effectsmay influenceNa+K+-ATPase and endothelial nitric oxide synthase activity in order to exert its beneficial effects
thusdesignedthus
a loss of phosphopeptidescausesa loss of phosphopeptides
long - term complications such as kidney failure- related kidney disease - diabetes was almost 0.7 million of lifecan ... causelong - term complications such as kidney failure- related kidney disease - diabetes was almost 0.7 million of life
from the ovine cathelicidinoriginatedfrom the ovine cathelicidin
to be stable in circulation but degradable at the target sitedesignedto be stable in circulation but degradable at the target site
from the InR.originatingfrom the InR.
for application by the athletes during the period of rehabilitation after injurieshas been designedfor application by the athletes during the period of rehabilitation after injuries